Cargando…

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment

In the present study, performed on a sample of Heroin Use Disorder (HUD) patients undergoing Opioid Agonist Treatment (OAT), we attempted to explore the relationships between stress sensitivity and heroin addiction-related clinical aspects. HUD patients’ stress sensitivity was evaluated with the Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Della Rocca, Filippo, Maremmani, Angelo G. I., Bacciardi, Silvia, Pacini, Matteo, Lamanna, Francesco, Tripodi, Beniamino, Miccoli, Mario, Maremmani, Icro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002439/
https://www.ncbi.nlm.nih.gov/pubmed/36901575
http://dx.doi.org/10.3390/ijerph20054566
_version_ 1784904390048481280
author Della Rocca, Filippo
Maremmani, Angelo G. I.
Bacciardi, Silvia
Pacini, Matteo
Lamanna, Francesco
Tripodi, Beniamino
Miccoli, Mario
Maremmani, Icro
author_facet Della Rocca, Filippo
Maremmani, Angelo G. I.
Bacciardi, Silvia
Pacini, Matteo
Lamanna, Francesco
Tripodi, Beniamino
Miccoli, Mario
Maremmani, Icro
author_sort Della Rocca, Filippo
collection PubMed
description In the present study, performed on a sample of Heroin Use Disorder (HUD) patients undergoing Opioid Agonist Treatment (OAT), we attempted to explore the relationships between stress sensitivity and heroin addiction-related clinical aspects. HUD patients’ stress sensitivity was evaluated with the Heroin/PTSD-Spectrum questionnaire (H/PSTD-S). The Drug Addiction History Questionnaire (DAH-Q), the Symptomatological Check List-90 (SCL-90), and The Behavioural Covariate of Heroin Craving inventory (CRAV-HERO) were all used, as were the Deltito Subjective Wellness Scale (D-SWS), a self-report scale evaluating subjective well-being; the Cocaine Problem Severity Index (CPSI), a questionnaire determining the extent of a cocaine problem; and the Marijuana Craving Questionnaire (MC-Q), an instrument assessing craving for cannabinoids. We checked correlations between stress sensitivity and the extent of HUD clinical features and compared patients with and without problematic stress sensitivity. H/PTSD-S was positively correlated with patients’ income, altered mental status, legal problems, the lifetime different treatments index, the current treatment load index, and all SCL-90 indexes and factors. Regarding subjective well-being, stress sensitivity negatively correlated with the contrast best week (last five years) index. Patients with high-stress sensitivity were females with a low income. They exhibited a more severe mental status at treatment entry, greater difficulty in working adaptation, and legal problems during treatment. Additionally, these patients showed a higher level of psychopathology, more impairment in well-being, and more risky behaviours during treatment. Stress sensitivity, as H/PTSD-S, must be considered an outcome of HUD. HUD’s addiction history and clinical features are significant risk factors for H/PTSD-S. Therefore, social and behavioural impairment in HUD patients could be considered the clinical expression of the H/PTSD spectrum. In summary, the long-term outcome of HUD is not represented by drug-taking behaviours. Rather, the inability to cope with the contingent environmental conditions is the key feature of such a disorder. H/PTSD-S, therefore, should be seen as a syndrome caused by an acquired inability (increased salience) concerning regular (daily) life events.
format Online
Article
Text
id pubmed-10002439
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100024392023-03-11 Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment Della Rocca, Filippo Maremmani, Angelo G. I. Bacciardi, Silvia Pacini, Matteo Lamanna, Francesco Tripodi, Beniamino Miccoli, Mario Maremmani, Icro Int J Environ Res Public Health Article In the present study, performed on a sample of Heroin Use Disorder (HUD) patients undergoing Opioid Agonist Treatment (OAT), we attempted to explore the relationships between stress sensitivity and heroin addiction-related clinical aspects. HUD patients’ stress sensitivity was evaluated with the Heroin/PTSD-Spectrum questionnaire (H/PSTD-S). The Drug Addiction History Questionnaire (DAH-Q), the Symptomatological Check List-90 (SCL-90), and The Behavioural Covariate of Heroin Craving inventory (CRAV-HERO) were all used, as were the Deltito Subjective Wellness Scale (D-SWS), a self-report scale evaluating subjective well-being; the Cocaine Problem Severity Index (CPSI), a questionnaire determining the extent of a cocaine problem; and the Marijuana Craving Questionnaire (MC-Q), an instrument assessing craving for cannabinoids. We checked correlations between stress sensitivity and the extent of HUD clinical features and compared patients with and without problematic stress sensitivity. H/PTSD-S was positively correlated with patients’ income, altered mental status, legal problems, the lifetime different treatments index, the current treatment load index, and all SCL-90 indexes and factors. Regarding subjective well-being, stress sensitivity negatively correlated with the contrast best week (last five years) index. Patients with high-stress sensitivity were females with a low income. They exhibited a more severe mental status at treatment entry, greater difficulty in working adaptation, and legal problems during treatment. Additionally, these patients showed a higher level of psychopathology, more impairment in well-being, and more risky behaviours during treatment. Stress sensitivity, as H/PTSD-S, must be considered an outcome of HUD. HUD’s addiction history and clinical features are significant risk factors for H/PTSD-S. Therefore, social and behavioural impairment in HUD patients could be considered the clinical expression of the H/PTSD spectrum. In summary, the long-term outcome of HUD is not represented by drug-taking behaviours. Rather, the inability to cope with the contingent environmental conditions is the key feature of such a disorder. H/PTSD-S, therefore, should be seen as a syndrome caused by an acquired inability (increased salience) concerning regular (daily) life events. MDPI 2023-03-04 /pmc/articles/PMC10002439/ /pubmed/36901575 http://dx.doi.org/10.3390/ijerph20054566 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Della Rocca, Filippo
Maremmani, Angelo G. I.
Bacciardi, Silvia
Pacini, Matteo
Lamanna, Francesco
Tripodi, Beniamino
Miccoli, Mario
Maremmani, Icro
Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
title Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
title_full Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
title_fullStr Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
title_full_unstemmed Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
title_short Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
title_sort characteristics of stress sensitivity in heroin use disorder patients during their opioid agonist treatment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002439/
https://www.ncbi.nlm.nih.gov/pubmed/36901575
http://dx.doi.org/10.3390/ijerph20054566
work_keys_str_mv AT dellaroccafilippo characteristicsofstresssensitivityinheroinusedisorderpatientsduringtheiropioidagonisttreatment
AT maremmaniangelogi characteristicsofstresssensitivityinheroinusedisorderpatientsduringtheiropioidagonisttreatment
AT bacciardisilvia characteristicsofstresssensitivityinheroinusedisorderpatientsduringtheiropioidagonisttreatment
AT pacinimatteo characteristicsofstresssensitivityinheroinusedisorderpatientsduringtheiropioidagonisttreatment
AT lamannafrancesco characteristicsofstresssensitivityinheroinusedisorderpatientsduringtheiropioidagonisttreatment
AT tripodibeniamino characteristicsofstresssensitivityinheroinusedisorderpatientsduringtheiropioidagonisttreatment
AT miccolimario characteristicsofstresssensitivityinheroinusedisorderpatientsduringtheiropioidagonisttreatment
AT maremmaniicro characteristicsofstresssensitivityinheroinusedisorderpatientsduringtheiropioidagonisttreatment